Status:
Awaiting development
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:
Selected as a pilot for the Whole Lifecycle Assessment (WLA) approach.
Process:
MTA Standard
ID number:
6689

Project Team

Project lead
Leena Issa

Email enquiries

If you have any queries please email TACommC@nice.org.uk

Timeline

Key events during the development of the guidance:

Date Update
13 January 2026 Awaiting development. Status change linked to topic prioritisation decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual